Trial Profile
The Efficacy of Intranasal Budesonide and Leukotriene ModifierTherapy for Mild-moderate Pediatric Obstructive Sleep Apnean Hypopnea Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Apr 2016
Price :
$35
*
At a glance
- Drugs Montelukast (Primary) ; Budesonide
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- 22 Jan 2013 New trial record